Research, Select, & Monitor Monday, November 18, 2019 12:43:08 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Rigel Pharmaceuticals Inc.$2.34$.052.18%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Rigel Pharmaceuticals Inc. vs Medical Labs & Research

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.

Most are providers of a broad range of diagnostic testing services to hospitals, patients, physicians, and managed care organizations. These can include magnetic-resonance imaging, gene mapping, hair sample testing, etc. Others in this category engage in contractual medical research to study the side effects of drugs about to come onto the market or conduct their own drug research.
 Totals Company Industry
  Sales: $44.5 Mil $20,844.4 Mil
  Market Cap: $392.2 Mil $37,115.4 Mil
  Analysts Recommendation: Strong Buy Strong Buy

 Averages Company Industry
  Historic Revenue: 893.5% 129.7%
  Estimated Revenue: N/A 9.0%
  Historic Earnings: N/A 30.0%
  Estimated Earnings: N/A 5.8%
  Stock Price (1 Year): (14.9%) 21.5%
  Cash per Share: 75.2% 26.4%
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: N/A 30.3
  Price-to-Sales: 4.8 N/A
  Price-to-Book: 3.5 3.5
  Dividend Yield: N/A N/A
  Market Cap: $392.2 Mil $4,639.4 Mil
  Net Margin: (56.8%) (.8%)
  Gross Margin: 99.3% 48.2%
  Return on Equity: (.6) .0
  Return on Assets: (.5) (.0)
  Balance Sheet
  Current Ratio: 4.9 2.9
  Quick Ratio: 4.9 2.8
  Cash Ratio: 4.6 2.0
  Debt-to-Equity: .3 .8
  Interest Coverage: N/A .6
  Relative-Strength Index: 66.5 N/A

 Other companies in Medical Labs & Research Price Market Cap
  Laboratory Corp. of America Holdings  (LH) $171.55 $16,863.4 Mil
  Quest Diagnostics, Inc.  (DGX) $104.22 $14,278.1 Mil
  CyberArk  (CYBR) $112.95 $4,411.6 Mil
  SP Plus Corporation  (SP) $43.91 $967.7 Mil
  Enzo Biochem Inc.  (ENZ) $2.90 $137.9 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2019 All rights reserved.